May 10, 2021 | BALTIMORE – Complete Omics’ Clinical Proteomics team announced a collaboration with Professor Zhenghe Wang and his team from the Case Western Researve University on a series of clinical proteomics projects focusing on leveraging our Complete360 targete detection pipeline for biological discoveries.
Dr. Zhenghe Wang received his Ph.D. in Microbiology from University of Virginia in 2001. He was a postdoctoral fellow with Dr. Bert Vogelstein in the Sydney Kimmel Comprehensive Cancer Center at Johns Hopkins University. Dr. Wang joined the Department of Genetics and the Case Comprehensive Cancer Center in August, 2005. He has been co-leader of the GI cancer genetics program at Case Comprehensive Cancer Center since 2014. He was named as a co-leader of the Standup to Cancer (SU2C) Colorectal Cancer Dream Team in 2017.
We are working with Dr. Wang on a series of novel discoveries that aiming for identifying several new biological mechanisms and new tumor suppressor genes critical for oncogenesis.
